@misc{indiciae034bcc58bd38,
  title = {BRD4-mediated repression of p53 is a target for combination therapy in AML},
  author = {Latif, A.-L. and Newcombe, A. and Li, S. and Gilroy, K. and Robertson, N. and Lei, X. and Stewart, H. and Cole, J. and Terradas, M. T. and Rishi, L. and McGarry, L. and McKeeve, C. and Reid, C. and Clark, W. and Campos, J. and Kirschner, K. and Davis, A. E. and Lopez, J. and Sakamaki, J.-I. and Morton, J. and Ryan, K. M. and Tait, S. and Abraham, S. and Holyoake, T. and Higgens, B. and Huang, X. and Blyth, K. and Copland, M. and Chevassut, T. and Keeshan, K. and Adams, P. D.},
  year = {2020},
  doi = {10.1101/2020.09.16.291930},
  url = {https://www.biorxiv.org/content/10.1101/2020.09.16.291930v1},
  note = {Source identifier: 10.1101/2020.09.16.291930}
}